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Abstract
Background: The objective of this study was to investigate the protective effects of molecular hydrogen, a novel
and selective antioxidant, on steroid-induced osteonecrosis (ON) in a rabbit model.
Methods: Sixty rabbits were randomly divided into two groups (model group and hydrogen group). Osteonecrosis
was induced according to an established protocol of steroid-induced ON. Rabbits in the hydrogen group were
treated with intraperitoneal injections of molecular hydrogen at 10 ml/kg body weight for seven consecutive days.
Plasma levels of total cholesterol, triglycerides, soluble thrombomodulin(sTM), glutathione(GSH) and
malondialdehyde(MDA) were measured before and after steroid administration. The presence or absence of ON
was examined histopathologically. Oxidative injury and vascular injury were assessed in vivo by
immunohistochemical staining of 8-hydoxy-2-deoxyguanosine(8-OHdG) and MDA, and ink artery infusion
angiography. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assays were
performed to measure apoptosis.
Results: The incidence of steroid-induced ON was significantly lower in hydrogen group (28.6%) than that in model
group (68.0%). No statistically differences were observed on the levels of total cholesterol and triglycerides.
Oxidative injury, vascular injury and apoptosis were attenuated in the hydrogen group compared with those
in the model group in vivo.
Conclusions: These results suggested that molecular hydrogen prevents steroid-induced osteonecrosis in rabbits
by suppressing oxidative injury, vascular injury and apoptosis.
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Background
Steroid-induced osteonecrosis(ON), especially at hip joint,
is one of the most common complications of corticoste-
roids. As most of the affected patients are young individ-
uals and the surgical prognosis of steroid-induced ON is
generally poor, it is highly desirable to develop a strategy
to prevent its occurrence. Hyperlipidemia, hypercoagula-
ble condition, fat emboli, intraosseous pressure rise with
fat cell enlargement, enhanced vasoconstriction and vas-
cular endothelial dysfunction after steroid administration
have been suggested to cause steroid-induced ON [1–3].
However, the detailed pathophysiological mechanisms of
steroid-induced ON remain unclear. It is generally
accepted that microcirculatory disturbances within bone
underlie the development of steroid-induced ON [4]. To
clarify the pathophysiology of steroid-induced ON and
develop promising methods to prevent its occurrence, a
number of preclinical animal ON models have been
established including traumatic ON(surgical vascular
deprivation, physical and chemical insult–induced trau-
matic ON) and non-traumatic ON(spontaneous, steroid-
induced or steroid-associated, lipopolysaccharide-induced
or their combination-induced, horse serum-induced and
alcohol-induced) [5]. Many researchers described steroid-
induced ON models in rabbits by administering methyl-
prednisolone intramuscularly, which had an advantage
* Correspondence: happylee_xjtu@163.com
1Department of Orthopedics, The First Affiliated Hospital of Xi’an Jiaotong
University, Yanta West Road, Xi’an, Shaanxi Province 710061, People’s
Republic of China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Li et al. BMC Musculoskeletal Disorders  (2017) 18:58 
DOI 10.1186/s12891-017-1431-6
with etiology similar to ON patients but also with disad-
vantages of only early-stage ON [6–8]. Multifocal ON le-
sions were identified histologically in the femora, implying
the effectiveness of this model for the evaluation of thera-
peutic efficacy of interventions developed for prevention
of steroid-induced ON.
Recently, it was indicated that oxidative stress, which
is associated with numerous pathological conditions
including vascular injury and cell apoptosis [9, 10], plays
a crucial role in the development of steroid-induced ON
[11]. More recently, the pro-oxidant buthionine sulphox-
imine has been proved to successfully induce ON in rats
model [12] and the antioxidative substances including
vitamin E [13, 14], glutathione (GSH) [11] and edaravone
[7] have been demonstrated to be effective in preventing
steroid-induced ON. Vascular injury and apoptosis, which
can be induced by oxidative stress [10, 11], also participate
in the development of steroid-induced ON [15, 16]. Thus,
we hypothesized that antioxidants may be effective in pre-
venting the development of steroid-induced ON by block-
ing the development of oxidative stress, vascular injury
and cell apoptosis.
In 2007, Ohsawa et al. [17] found that diatomic hydro-
gen(H2) could selectively reduce cytotoxic reactive oxygen
species(ROS) including hydroxyl radical (•OH) and perox-
ynitrite(ONOO-), without affecting physiological ROS
including H2O2 and the nitric oxide radical (NO•), which
have been shown to play important roles in immune de-
fence systems and signal transduction [18–20]. Moreover,
in a rat model of ischaemia–reperfusion brain injury, he
and his colleagues observed that molecular hydrogen is
more effective than edaravone and as effective as FK506 in
alleviating oxidative injury, which indicated the potential
of molecular hydrogen for therapy. Then, molecular
hydrogen was proposed as a novel and selective antioxi-
dant and researches on the potential use of hydrogen as
therapeutic agents in various diseases were conducted. It
was showed that hydrogen can exert beneficial effects in
diverse diseases of animal models related to oxidative
stress, including ischaemia–reperfusion injury, radiation
complication, atherosclerosis and sepsis [21–24]. Besides,
it was reported that administration of H2-saturated water
can also improve lipid metabolism [25–27]. Compared
with other antioxidants such as vitamin E, vitamin C and
edaravone, hydrogen gas can diffuse rapidly into tissue
and subcellular compartments including mitochondria
and the nucleus, and can further eliminate ROS generated
in mitochondria and protect DNA from oxidative damage
in nuclear [17]. Accordingly, we assumed that molecular
hydrogen might exert beneficial effects on preventing
steroid-induced ON by reducing oxidative stress and
apoptosis. The aim of this study was to test whether
hydrogen can prevent the development of steroid-induced
ON and the possible mechanisms involved.
Methods
Animal, grouping and treatment
All the animals used were housed at the Experimental
Animal Center of Xi’an Jiaotong University, China and
were maintained on the standard laboratory diet and
water ad libitum. All protocols were approved by the
Animal Ethical Committee of the Xi’an Jiaotong University
and were followed in accordance with the NIH Guide for
the Care and Use of Laboratory Animals.
Sixty mature male New Zealand rabbits (age: 28 weeks)
were divided into two groups (model group and hydro-
gen group), each containing 30 rabbits. Osteonecrosis
was induced in both groups by methods according to
the previously published protocols [6, 7]. Briefly, the
rabbits received an intramuscular injection of 20 mg/kg
body weight of methylpednisolone acetate (MPSL, Pfizer
Pharmaceutical, China) into the right gluteus medius
muscle. In addition to MPSL, the hydrogen group also
received intraperitoneal injections of molecular hydro-
gen at 10 ml/kg body weight for seven consecutive days
starting from the day of MPSL administration, which
was based on the period of greatest susceptibility to
steroid-induced oxidative injury suggested by Ichiseki et
al. [11, 28].
Haematological examination
The blood samples were obtained from the auricular
artery of each rabbit in a fasting state immediately
before injection of MPSL(day 0) and 3, 5, 7, 14 days
after the MPSL injection. Blood samples were col-
lected at the same time of the day. The levels of total
cholesterol (T-cho; mg/dL), triglycerides (TG; mg/dL)
and soluble thrombomodulin (sTM; ug/L) at day 0, 7,
14 and the level of GSH(ug/mL) and MDA(umol/L)
at day 0, 3, 5, 7, 14 were determined.
Histopathology
Two weeks after steroid administration, the rabbits were
killed with an overdose of sodium pentobarbital. Bilat-
eral femurs were obtained for histological analyses. For
HE staining, bone samples were fixed with 10% neutral
buffered formalin for 1 week, decalcified with 10% ethyl-
ene diamine tetraacetic acid (EDTA) for 4 weeks, then
embedded in paraffin, cut into 4 μm thick sections and
stained with hematoxylin-eosin. The bone samples were
cut along the coronal plane in the proximal one third
and axial plane in the distal part (condyle).
Whole areas of bilateral femoral samples, including the
proximal one-thirds and distal condyles, were histopatho-
logically examined for the presence of ON. A positive
diagnosis of ON was determined based on the diffuse
presence of empty lacunae or pyknotic nuclei of osteo-
cytes within the bone trabeculae, accompanied by sur-
rounding bone marrow cell necrosis or fat cell necrosis
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[29]. 8 sections were taken from the proximal one-thirds
and distal condyles of both femurs of each rabbit. The
presence or absence of ON was determined using well
established criteria [29, 30]. Briefly, rabbits that had at
least one osteonecrotic lesion in the 8 sections were
considered as ON+, while those with no osteonecrotic
lesions were defined as ON−. Besides, the incidence of
ON was calculated as the ratio of the number of rabbits
with ON/total number of rabbits used in each group.
During the observation, the average bone marrow fat
cell size was calculated using image analysis software
(ImageJ 1.32j, NIH, USA). As described in previous re-
ports, the average bone marrow fat cell size was defined
as the average of the Feret’s diameter of all bone marrow
fat cells in 4 randomly-selected non-necrotic fields (16
fields for 4 dissected parts from each rabbit). Fat cells
that had undergone necrosis were excluded from
imaging analysis. During the observation, both the judg-
ment of osteonecrosis and the calculation of average fat
cell size were performed by two researchers who were
blind to the identity of the hydrogen group.
Ink artery infusion angiography
Two weeks after steroid administration, the rabbits were
anesthetized with sodium pentobarbital and ink artery
infusion angiography was performed to investigate vas-
cular injury in the femur according to the previously
published protocol [31]. After the infusion, the animals
were then euthanized and stored at 4 °C for 24 h. Then
the bilateral thighbones were dissected and the samples
were fixed, decalcified, embedded and cut into 5-μm-
thick slices. Ink leakage would be observed if vascular
permeability increased which was induced by vascular
injury.
Immunohistochemistry
To determine the level of oxidative injury, the femurs were
stained immunohistochemically with anti-8-hydoxy-2-
deoxyguanosine (8-OHdG) monoclonal antibody (N45.1)
and anti-malondialdehyde (MDA) monoclonal antibody
(clone 1 F83) which was major marker of DNA oxidative
injury and lipid peroxide respectively [14, 28]. Briefly,
sections were immersed in 3% hydrogen peroxide PBS for
10 min, rinsed several times in PBS, pretreated with 10%
goat normal antiserum(Vector, Burlingame, California,
USA) for 30 min at room temperature. Then, sections were
reacted with a primary antibody overnight at 4 °C and
incubated with the biotinylated secondary antibody for
30 min, followed by streptavidin peroxidases for 30 min at
room temperature. Finally, sections were treated with
diaminobenzidine solution, counterstained with haema-
toxylin and mounted. Sections without primary antibodies
processing were used as the negative control. The sections
were observed and photographed by the eclipse 50i optical
microscope imaging system (Nikon Co., Ltd., Tokyo,
Japan).
To quantify DNA oxidation injury and vascular dam-
age of immunohistological results, the 8-OHdG positive
area per visual field (PA%) and the MDA positive mar-
row vessels were calculated by image analysis software
(ImageJ 1.32j, NIH, USA). DNA oxidative injury was
evaluated by calculating the %PA of 8-OHdG, the
percentage of 8-OHdG positive area/total area, in 5
randomly selected visual fields (×200 magnification) [7].
Vascular damage was evaluated by counting the number
of MDA positive marrow vessels in 5 randomly-selected
fields from the proximal one-third of the femur (×100
magnification) [14].
TUNEL assays
The terminal deoxynucleotidyl transferase-mediated
dUTP nick end labeling (TUNEL) assays were performed
by using the TUNEL detection kit (Promega Co., Ltd.,
Beijing, China) to observe apoptotic osteoblasts and osteo-
cytes according to the manufacturer’s instructions. The
cells with brown nuclei were assessed as positive. During
the observation of per tissue slide at 200 times magnifica-
tion, the apoptotic rate was calculated by two blinded
researchers. The apoptotic rate was defined as number
of TUNEL-positive cells/number of all cells. Besides,
morphological changes characteristic of apoptosis were
examined carefully to minimize ambiguity regarding
the interpretation of positive results.
Statistical analysis
Categorical data, i.e. incidence of osteonecrosis, was ana-
lyzed using Pearson’s chi-square test. All the numerical
data were described as mean ± standard deviation.
Simple comparisons of numerical data were performed
using Student’s t-test. To compare the serial changes of
GSH and MDA levels in each group, a repeated-
measures analysis of variance (ANOVA) was used. To
compare the changes in GSH and MDA values between
the hydrogen group and the model group, a two-way
ANOVA was used. The SPSS 17.0 software was used for
analysis. P values < 0.05 were considered significant.
Results
Histopathological observations
Seven of the 60 rabbits (5 in the model group and 2 in
the hydrogen group) died of the inductive protocol
throughout the experiment period and were excluded
from the evaluation.
Osteonecrosis was observed in 17 of the 25 rabbits in
the model group and in 8 of 28 rabbits in the hydrogen
group (Fig. 1). The incidence of osteonecrosis was
significantly lower in the hydrogen group than that in the
model group (Pearson’s chi-square test, P < 0.01). The size
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of fat cells was 57.3 ± 5.8 μm in the model group and 53.6
± 6.2 μm in the hydrogen group (P >0.05).
Hematological findings
Hematological data were compared both between different
time points in the same group and between the model
group and the hydrogen group at the same time points.
The levels of total cholesterol and triglycerides in both
groups increased during the period from day 7 to day 14
after MPSL administration (P < 0.05). However, there was
no difference between the two groups at all the same time
points (P > 0.05) (Fig. 2a and b). The sTM level sig-
nificantly increased at day 7 in the model group and
then declined toward baseline. However, in the hydrogen
group, the significant increase of sTM was prevented
(Fig. 2c). In the model group, the GSH level was signifi-
cantly decreased between 3 and 7 days after steroid ad-
ministration (P < 0.05), followed by a tendency to recover
by 7–14 days after administration. The MDA level was
significantly increased between 5 and 7 days after steroid
administration (P < 0.05) and appeared to recover by 7–14
days after administration in the model group. Both de-
creases in GSH and increases in MDA of the hydrogen
group were significantly attenuated compared with those
in the model group (Fig. 2d and e). In the hydrogen group,
the decrease of GSH level was significantly suppressed on
days 3 and 5 after MPSL administration (P < 0.05), and
the increase of MDA level was significantly suppressed on
day 7 after MPSL administration (P < 0.05).
Oxidative stress and vascular injury in the proximal femurs
In marrow of the model group, clusters of 8-OHdG-
positive haematopoietic cells were present (Fig. 3a).
However, marrow of the hydrogen group showed only a
few, sporadic 8-OHdG-positive haematopoietic cells
(Fig. 3b). Furthermore, 8-OHdG %PA was 2.3 ± 0.5% in
the hydrogen group (Fig. 3c), significantly lower than
5.4 ± 0.8% in the model group (P < 0.01).
In the model group, strong immunoreactivity for
MDA was found in marrow vessels and haematopoietic
cells (Fig. 3d), whereas weak immunoreactivity for MDA
was found in the hydrogen group (Fig. 3e). Furthermore,
the number of MDA positive vessels was 4.1 ± 1.9 in the
model group (Fig. 3f ). In the hydrogen group, a smaller
number of MDA positive vessels, 1.8 ± 1.0, was observed
(P < 0.01).
Stronger ink leakage indicating increased vascular
permeability was observed more often in the model
group (Fig 3g). In the hydrogen group, less ink leakage
was observed (Fig. 3h).
Apoptosis in the proximal femurs
In the model group, many TUNEL-positive osteoblasts
and osteocytes were observed (Fig. 4a). However, few
Fig. 1 Histological observation. a Representative ON+ sample in the model group showed more empty lacunae within the bone trabeculae (indicated
by white arrow), surrounded by necrotic medullary haematopoietic cells and necrotic fat cells(indicated by black arrow). b Representative ON− sample
in the hydrogen group showed less empty lacunae or osteocytes having pycnotic nuclei, surrounded by abundant normal marrow hematopoietic
cells. c The ON incidence in the hydrogen group was significantly lower than that of the model group (P < 0.01). d There were no statistical difference
about the size of fat cells between the hydrogen group and the model group (P > 0.05). N.S., not significant
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and sporadic TUNEL-positive osteoblasts and osteocytes
were observed in hydrogen group (Fig. 4b), which indi-
cated that the administration of molecular hydrogen
protected the trabecular bone cells from apoptosis.
Discussion
Circulatory disturbance [32], vascular endothelial dys-
function [33], enhanced vasoconstriction [3], thrombotic
and fibrinolytic disorders [2, 34], impairment of lipid
metabolism [35], increased oxidative stress [11, 28] and
apoptosis [36] have been suggested to exert important
roles in the development of steroid-induced osteonecrosis
(ON). Many drugs to inhibit these, including lipid-
lowering drugs (Statin) [6, 37], anticoagulants (Enoxa-
parin) [2, 38, 39], antioxidants (Vitamin E, Lipoic acid,
Edaravone) [7, 13, 14, 40] and vasodilation drugs [3] have
been reported to effectively prevent or suppress the pro-
gression of steroid-induced ON in animals and humans.
In the present study, we selected hydrogen gas, which was
reported to decrease oxidative injury in various diseases
related to oxidative stress and optimize lipid metabolism,
as therapy for steroid-induced ON in an established rabbit
model. We found that hydrogen therapy significantly
decreased the incidence of steroid-induced ON in rabbits
to 28% as compared with 68% in the model group, and
attenuated both the decreases in plasma levels of GSH
and the increases in plasma levels of MDA and sTM
compared with those in the model group. Locally in the
proximal femurs, DNA oxidative injury, lipid peroxide
and vascular endothelial injury, indicated by immunohis-
tochemistry for 8-OHdG, MDA and ink artery infusion
angiography respectively, were decreased after hydrogen
administration. However, effects of hydrogen on the levels
of total cholesterol and triglycerides were not observed.
Disorders of lipid metabolism which resulted in extra-
vascular lipid deposition and elevated intraosseous
pressure, played an important role in the etiology of
steroid-induced ON [35]. In the present study, disorders
of lipid metabolism were evaluated by measuring the
levels of total cholesterol and triglycerides as well as fat
cell size. Total cholesterol, triglycerides and the fat cell
size elevated after steroid administration which was
consistent with findings by Kuribayashi et al. [14]. Study
by Zong et al. [26] demonstrated that in high-fat diet-fed
hamster model, 4-week intraperitoneal injection of
hydrogen-saturated saline remarkably decreases plasma
total cholesterol and low-density lipoprotein (LDL)
cholesterol levels. In an open label, 8-week study on 20
Fig. 2 The levels of total cholesterol (a), triglycerides (b), soluble thrombomodulin (c), glutathione (d) and malondialdehyde (e). #P < 0.05 for
comparison with baseline; *P < 0.05 for comparison with the model group. N.S., not significant for comparison with the model group
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Fig. 3 Oxidative stress and vascular injury in the proximal femurs. a The model group showed clusters of 8-OHdG-positive haematopoietic cells in
marrow. b In the hydrogen group, sporadic 8-OHdG-positive haematopoietic cells were found. c The hydrogen group exhibited a lower 8-OHdG
%PA than the model group (P < 0.01). d Strong immunoreactivity for MDA was found in marrow vessels and haematopoietic cells of the model
group. e The hydrogen group exhibited weak immunoreactivity for MDA in marrow vessels and haematopoietic cells. f A smaller number of MDA
positive vessels was found in the hydrogen group than the model group (P < 0.01). g Stronger ink leakage was observed in the model group.
h The hydrogen group showed less ink leakage
Fig. 4 TUNEL apoptosis detection. a The model group showed many apoptotic osteoblasts and osteocytes. b In the hydrogen group, few
TUNEL-positive osteoblasts and osteocytes were found. c The apoptotic rate in the hydrogen group was significantly lower than that of the
model group (P < 0.01)
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subjects with potential metabolic syndrome, Nakao et al.
found administration of hydrogen rich water for 4 weeks
increases high density lipoprotein (HDL)-cholesterol and
decreases total cholesterol/high-density lipoprotein(HDL)-
cholesterol [25]. In addition, study of Kamimura et al. in-
dicated that consuming molecular hydrogen for 3 months
suppresses plasma triglyceride level in db/db obesity
model mice [27]. In our study, no statistically significant
differences about the level of total cholesterol, triglycerides
and the fat cell size were found between the model group
and the hydrogen group, indicating that disorders of lipid
metabolism was not improved by hydrogen during
the 2-week duration for observation and some other
osteonecrosis-prevention mechanisms exist other than
disorders of lipid metabolism. Considering that the
beneficial effects of molecular hydrogen on lipid metabol-
ism were based on long-term molecular hydrogen admin-
istration, the period of hydrogen treatment and duration
for observation should be extended to determine the long-
term efficacy of hydrogen treatment on disorders of lipid
metabolism in steroid-induced ON.
Increased oxidative stress in the etiology of steroid-
induced ON has been well documented [7, 11, 13, 14,
28, 40]. In the present study, we measured the blood
levels of GSH and MDA which generally reflect the
development of oxidative stress in the body. GSH is an
important antioxidant enzyme in vivo and exerts a
crucial role in maintaining integrity of cell structure by
inhibiting the increase of lipoperoxides and maintaining
redox reaction balance. MDA is generated during the
hyperoxidation of lipids and can be used as a biochem-
ical indicator of oxidative injury. In our study, we found
that GSH levels significantly decreased and MDA levels
significantly increased shortly after MPSL administra-
tion. The results were in accord with those of Ichiseki et
al. [11], Mikami et al. [13], Kuribayashi et al. [14] and Li
et al. [7]. In addition, we detected the local expression of
8-OHdG and MDA, which was major marker of DNA
oxidative injury and lipid peroxide respectively, in the
femurs. Consistent with findings of previous studies
[7, 14, 28], the number of both 8-OHdG-positive haem-
atopoietic cells and MDA-positive haematopoietic cells in-
creased. In the prevention group treated with hydrogen,
we found that the decrease of GSH and increase of MDA
in plasma caused by steroid were significantly attenuated
by hydrogen administration. Moreover, the number of
both 8-OHdG-positive haematopoietic cells and MDA-
positive haematopoietic cells in marrow, and the 8-OHdG
positive area per visual field (8-OHdG PA%) decreased in
group received hydrogen therapy. This demonstrated that
hydrogen could systemically and locally reduce oxidative
stress caused by steroid.
Vascular endothelial dysfunction injury was one of the
factors that participate in the development of steroid-
induced ON [33, 41]. It was reported that lipid peroxide
could markedly damage vascular endothelial cells [42]
and induce vascular endothelial dysfunction accompany-
ing with oxidative injury in steroid-induced ON [11, 40].
In our study, the results of immunohistochemical stain-
ing for MDA and ink artery infusion angiography in the
group only received steroid indicated that bone marrow
vessels suffered from extensive oxidative injury caused
by steroid administration. However, hydrogen adminis-
tration reduced the number of MDA-positive vessels in
marrow compared with the model group, indicating
that hydrogen considerably decreased the damage of
steroid-induced oxidative stress to endothelial cells.
Furthermore, we determined the level of soluble
thrombomodulin(sTM) in plasma which is an index
of endothelial injury. We found that sTM significantly
increased in the model group at day 7 post induction
and hydrogen reduced the sTM concentration.
Roles of apoptosis in steroid-induced ON were reported
in several studies [15, 43]. Oxidative stress is an important
contributor to apoptosis [10]. The results of TUNEL assay
in our study demonstrated that molecular hydrogen de-
creased the number of apoptotic osteoblasts and osteo-
cytes, which was in accord with the decrease of oxidative
stress. It indicated that molecular hydrogen might indir-
ectly inhibit apoptosis by suppressing oxidative stress.
Compared with conventional antioxidants, diatomic
hydrogen has several potential advantages [17]. First,
hydrogen is highly diffusible and it can penetrate
biomembranes and diffuse into the mitochondria and
nucleus, which are the primary site of ROS generation
and DNA damage. Secondly, diatomic hydrogen(H2)
could selectively reduce level of hydroxyl radical (•OH)
and peroxynitrite (ONOO-) which are the most aggres-
sive ROS, but do not affect the level of H2O2 and the
nitric oxide radical (NO•) which play physiological roles
in immune defence systems and signal transduction.
Thirdly, diatomic hydrogen exerts antioxidative effects
with few toxic side effects at effective dosages. Finally, it
is cheaper than conventional pharmaceuticals.
One of the limitations of the present study is that we
limited the delivery of hydrogen gas to intraperitoneal in-
jection and limited the therapeutic dose of hydrogen to
10 ml/kg. We were unable to determine the optimum way
of hydrogen administering and the optimum level of
hydrogen. In addition, we did not clarify the further mech-
anisms at the gene level which might help us to better
understand the preventive effects of hydrogen on osteo-
necrosis. However, it was indicated that genes for
oxidoreduction-related proteins were up-regulated in the
livers of rats after 4 weeks of drinking hydrogen-rich water
[44]. This might partially clarify the antioxidative effects of
hydrogen on osteonecrosis. Thus, in the near future, we
will conduct additional studies to determine the optimum
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level of hydrogen that can prevent the development of
osteonecrosis. Besides, we will determine the changes of
oxidoreduction-related genes in the femurs after hydrogen
administration.
Conclusions
In conclusion, the present results suggest that oxidative
stress participated in the development of steroid-
induced ON and molecular hydrogen could significantly
reduce the incidence of steroid-induced ON possibly by
systemically and locally reducing oxidative stress and
endothelial injury. This might offer a novel and simple
method to prevent the development of steroid-induced
ON. Furthermore, the long-term efficacy of molecular
hydrogen therapy on disorders of lipid metabolism in
steroid-induced ON needs to be explored.
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